NSCLC Treatment Paradigm: Where Do We Stand? NSCLC treatment paradigm: where do we stand? Lung cancer is, by a large margin, the leading cause [...]
Medimix International today announced that it has launched a campaign to support cancer research by proposing to the members of its global HCP community to match dollar for dollar the portion of their honoraria they would donate for research against cancer. The first donations will go to the Cancer Research Institute, one of the highest ranked charities for cancer research.